Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3486.17 | 2642 / 2642 | 100% | 64.89 | 705 / 705 |
esophagus | 100% | 2276.61 | 1445 / 1445 | 100% | 25.50 | 183 / 183 |
lung | 100% | 2359.95 | 578 / 578 | 100% | 25.88 | 1155 / 1155 |
breast | 100% | 2514.58 | 459 / 459 | 100% | 27.77 | 1113 / 1118 |
bladder | 100% | 2597.67 | 21 / 21 | 99% | 23.70 | 501 / 504 |
adrenal gland | 100% | 4605.61 | 258 / 258 | 99% | 32.54 | 228 / 230 |
prostate | 100% | 1929.75 | 244 / 245 | 99% | 24.19 | 498 / 502 |
thymus | 100% | 2313.58 | 653 / 653 | 99% | 24.38 | 596 / 605 |
uterus | 100% | 1947.15 | 170 / 170 | 98% | 21.05 | 451 / 459 |
stomach | 100% | 1726.62 | 359 / 359 | 98% | 17.89 | 281 / 286 |
ovary | 100% | 2196.03 | 180 / 180 | 98% | 13.86 | 422 / 430 |
intestine | 100% | 2069.80 | 966 / 966 | 98% | 19.15 | 516 / 527 |
kidney | 100% | 2019.46 | 89 / 89 | 98% | 24.77 | 879 / 901 |
pancreas | 96% | 1030.13 | 316 / 328 | 98% | 22.35 | 175 / 178 |
liver | 100% | 1786.61 | 226 / 226 | 94% | 13.74 | 381 / 406 |
skin | 100% | 2299.16 | 1808 / 1809 | 93% | 24.59 | 440 / 472 |
blood vessel | 100% | 2345.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.79 | 29 / 29 |
muscle | 100% | 3496.28 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1632.12 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.25 | 1 / 1 |
adipose | 100% | 2899.42 | 1203 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 21.80 | 44 / 45 |
heart | 96% | 1987.26 | 825 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 1431.61 | 832 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 7.91 | 50 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070328 | Biological process | triglyceride homeostasis |
GO_0043651 | Biological process | linoleic acid metabolic process |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0034638 | Biological process | phosphatidylcholine catabolic process |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0046338 | Biological process | phosphatidylethanolamine catabolic process |
GO_0001516 | Biological process | prostaglandin biosynthetic process |
GO_0032048 | Biological process | cardiolipin metabolic process |
GO_1900407 | Biological process | regulation of cellular response to oxidative stress |
GO_0055088 | Biological process | lipid homeostasis |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005777 | Cellular component | peroxisome |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0047499 | Molecular function | calcium-independent phospholipase A2 activity |
GO_0004622 | Molecular function | lysophospholipase activity |
GO_0102545 | Molecular function | phosphatidyl phospholipase B activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | PNPLA8 |
Protein name | Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (PNPLA-gamma) (Patatin-like phospholipase domain-containing protein 8) (iPLA2-2) Patatin like phospholipase domain containing 8 |
Synonyms | BM-043 IPLA22 IPLA2G |
Description | FUNCTION: Calcium-independent and membrane-bound phospholipase, that catalyzes the esterolytic cleavage of fatty acids from glycerophospholipids to yield free fatty acids and lysophospholipids, hence regulating membrane physical properties and the release of lipid second messengers and growth factors . Hydrolyzes phosphatidylethanolamine, phosphatidylcholine and probably phosphatidylinositol with a possible preference for the former . Has also a broad substrate specificity in terms of fatty acid moieties, hydrolyzing saturated and mono-unsaturated fatty acids at nearly equal rates from either the sn-1 or sn-2 position in diacyl phosphatidylcholine . However, has a weak activity toward polyunsaturated fatty acids at the sn-2 position, and thereby favors the production of 2-arachidonoyl lysophosphatidylcholine, a key branch point metabolite in eicosanoid signaling . On the other hand, can produce arachidonic acid from the sn-1 position of diacyl phospholipid and from the sn-2 position of arachidonate-containing plasmalogen substrates . Therefore, plays an important role in the mobilization of arachidonic acid in response to cellular stimuli and the generation of lipid second messengers . Can also hydrolyze lysophosphatidylcholine . In the mitochondrial compartment, catalyzes the hydrolysis and release of oxidized aliphatic chains from cardiolipin and integrates mitochondrial bioenergetics and signaling. It is essential for maintaining efficient bioenergetic mitochondrial function through tailoring mitochondrial membrane lipid metabolism and composition . . |
Accessions | ENST00000426128.6 [Q9NP80-2] C9JAX4 ENST00000453085.1 ENST00000257694.13 [Q9NP80-1] A0A0C4DG51 ENST00000415498.2 Q9NP80 ENST00000436062.5 [Q9NP80-1] ENST00000453144.5 [Q9NP80-3] ENST00000427008.1 ENST00000422087.5 [Q9NP80-1] C9J9W9 |